Dr. Jonathan Hollander Kaplan, MD

Dr. Kaplan practices at Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare.

Dr. Kaplan's NPI, 1821451089, was assigned on April 4, 2016. Dr. Kaplan holds California license A177078.

Dr. Kaplan's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Drive Box 58, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 465-0711.

Dr. Kaplan's primary practice is Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare. The medical group on file is TeamHealth. Dmand AI also links Dr. Kaplan to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaplan practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kaplan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Kaplan's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 962 Medicare services from Dr. Kaplan across 5 procedure codes in 2024, for 642 Medicare patients. Medicare paid $89,079 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 642 Medicare patients who saw Dr. Kaplan in 2024. The largest group is 65 to 74, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaplan's median patient age at 44, with 56% women.

In 2024, Dr. Kaplan wrote 326 Medicare Part D claims for 230 patients. 96% of them were for generic drugs. CMS names the drug for 223 of them, across 9 drugs with 11 or more claims each, at $2,517 in total drug cost. In 2023, CMS named 128 claims across 7 drugs.

Dr. Kaplan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Kaplan from 3 drug and device companies in 2025. Grants make up the largest share, 92% of the total. Medtronic, Inc. paid the most, $1,841.